Aspire Biopharma stockholders approve three warrant-related proposals at special meeting

Aspire Biopharma Holdings, Inc.

Warrant Issuance Proposal: 1,742,683 for, 107,523 against, 4,818 withheld, 0 non-votes.
Share Adjustment Proposal: 1,745,709 for, 103,550 against, 5,764 withheld, 0 non-votes.
Exercise Price Adjustment Proposal: 1,739,702 for, 110,483 against, 4,839 withheld, 0 non-votes.
All proposals related to warrants on common stock (ASBP) and warrants (ASBPW) under terms of Warrant Agreement dated March 17, 2026.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Aspire Biopharma Holdings, Inc. shareholders approved To approve adjustment of number of shares of common stock issuable upon exercise of warrants (Share Adjustment Proposal) at the 2026-06-16 meeting.

Outcome: passed
Meeting: 2026-06-16

Exact text from the filing

The number of shares that voted for, against, and withheld from voting for this Share Adjustment Proposal is summarized in the table below: Votes Non-Votes 1,745,709 103,550 5,764 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Aspire Biopharma Holdings, Inc. shareholders approved To approve voluntary adjustments to the exercise price of the warrants (Exercise Price Adjustment Proposal) at the 2026-06-16 meeting.

Outcome: passed
Meeting: 2026-06-16

Exact text from the filing

The number of shares that voted for, against, and withheld from voting for this Exercise Price Adjustment Proposal is summarized in the table below: Votes Non-Votes 1,739,702 110,483 4,839 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Aspire Biopharma Holdings, Inc. shareholders approved To authorize issuance of shares of common stock upon exercise of warrants (Warrant Issuance Proposal) at the 2026-06-16 meeting.

Outcome: passed
Meeting: 2026-06-16

Exact text from the filing

The number of shares that voted for, against, and withheld from voting for this Warrant Issuance Proposal is summarized in the table below: Votes Non-Votes 1,742,683 107,523 4,818 0

View on SEC.gov

1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Aspire Biopharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-029599

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.